Tag: Coronavirus information (COVID-19)
Press Releases
Approvals of COVID-19 biologics will put huge pressure on large-scale bioprocessing networks, according to CPhI Annual Report
The third part of the 2020 CPhI Annual Report – released during the second week of the CPhI Festival of Pharma (5-16 October, 2020)...
News
After Sputnik V, Russia grants approval to 2nd COVID-19 vaccine EpiVacCorona
Russia announced that it has granted regulatory approval to another Covid-19 vaccine named EpiVacCorona. This comes after the country granted similar approval to Sputnik...
News
Pfizer Gets FDA OK to Test Adolescents in COVID-19 Vaccine Trial
To date, all the major clinical trials of vaccines against COVID-19 have been in adults. Typically, Phase I safety trials were in healthy volunteers...
News
UK joins global trial to test BCG vaccine against COVID-19
A global trial, designed to test the theory that the BCG vaccine could help protect against COVID-19, will soon start recruitment in the UK.
Led...
News
Kindred Bio Expands of Manufacturing Agreement with Vaxart for COVID-19 Vaccine
Kindred Biosciences, Inc., a biopharmaceutical company developing novel biologics, announced it has expanded an agreement with Vaxart, Inc. for the manufacture of Vaxart’s oral...
News
Direct Biologics Granted Expanded Access by FDA for ExoFlo in the Treatment of COVID-19
Direct Biologics, LLC, announced that the FDA has granted expanded access for ExoFlo in the treatment of patients with COVID-19 associated acute respiratory distress...
Clinical Trials
Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials
AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read